303030 — Zinitix Co Balance Sheet
0.000.00%
- KR₩36bn
- KR₩28bn
- KR₩54bn
Annual balance sheet for Zinitix Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 19,114 | 20,366 | 11,052 | 7,953 | 12,139 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4,128 | 6,403 | 2,967 | 5,479 | 5,606 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 30,160 | 33,849 | 24,427 | 21,921 | 21,624 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,858 | 4,849 | 4,890 | 4,715 | 4,523 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 41,678 | 43,369 | 30,933 | 28,538 | 27,629 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9,636 | 10,761 | 7,878 | 11,093 | 9,265 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 11,459 | 13,290 | 9,064 | 12,335 | 10,690 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Total Equity | 30,218 | 30,078 | 21,869 | 16,202 | 16,939 |
Total Liabilities & Shareholders' Equity | 41,678 | 43,369 | 30,933 | 28,538 | 27,629 |
Total Common Shares Outstanding |